Cited by 188Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease

Open access
Stakos, Dimitrios A., Stamatelopoulos, Kimon, Bampatsias, Dimitrios, Sachse, Marco, Zormpas, Eleftherios, Vlachogiannis, Nikolaos I., Tual-Chalot, Simon, Stellos, Konstantinos·2020·Journal of the American College of Cardiology

Abstract

Aging-related cellular and molecular processes including low-grade inflammation are major players in the pathogenesis of cardiovascular disease (CVD) and Alzheimer's disease (AD). Epidemiological studies report an independent interaction between the development of dementia and the incidence of CVD in several populations, suggesting the presence of overlapping molecular mechanisms. Accumulating experimental and clinical evidence suggests that amyloid-beta (Aβ) peptides may function as a link among aging, CVD, and AD. Aging-related vascular and cardiac deposition of Αβ induces tissue inflammation and organ dysfunction, both important components of the Alzheimer's disease amyloid hypothesis. In this review, the authors describe the determinants of Aβ metabolism, summarize the effects of Aβ on atherothrombosis and cardiac dysfunction, discuss the clinical value of Αβ1-40 in CVD prognosis and patient risk stratification, and present the therapeutic interventions that may alter Aβ metabolism in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.12.033

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APP/PS1-F5KO mice have higher cortical soluble Aβ−40 levels than APP/PS1-WT mice, with no such difference in hippocampus.

    “Interestingly, in the cortex, APP/PS1-F5KO showed significantly higher levels of soluble Aβ−40, which contributes to plaque formation and more dysfunctional vascular integrity 54,55, compared to APP/PS1-WT However, the hippocampus did not present such differences (Extended Data Fig. 5a, b).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 121 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S., & Stellos, K.
Affiliations
  • Democritus University of Thrace (GR)
  • National and Kapodistrian University of Athens (GR)
  • Goethe University Frankfurt (DE)
  • Newcastle University (GB)
  • Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
Corresponding author
Stellos, Konstantinos
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2020-03
Volume
75
Issue
8
Pages
952-967
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3007333794
Cited by
188
References
121
Citations by year
2026: 16 · 2025: 45 · 2024: 32 · 2023: 35 · 2022: 25 · 2021: 23 · 2020: 12
FWCI
3.02
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • European Research Council
  • Deutsche Forschungsgemeinschaft (75732319, SFB834)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, amyloid-beta, amyloid hypothesis, cardiovascular aging, cardiovascular disease, dementia, low-grade inflammation, atherothrombosis, cardiac dysfunction, amyloid-beta metabolism, Aβ40, risk stratification, Alzheimer's disease therapeutics
MeSH terms
Aging, Alzheimer Disease, Animals, Cardiovascular Diseases, Humans, Mortality, Amyloid beta-Peptides, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review